HIV InfectionsHIV-1HIV SeropositivityViral LoadHomosexuality, MaleRhabdomyolysisAnti-HIV AgentsHIVAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountAcquired Immunodeficiency SyndromeSexual BehaviorHIV AntibodiesRNA, ViralReceptors, CCR5CD8-Positive T-LymphocytesCD4-Positive T-LymphocytesAcute DiseaseCohort StudiesDisease ProgressionHIV SeroprevalenceTime FactorsHIV SeronegativityMolecular Sequence DataAIDS SerodiagnosisHIV AntigensHIV Protease InhibitorsRisk-TakingAnti-Retroviral AgentsHIV Core Protein p24HIV Reverse TranscriptaseSouth AfricaHIV Envelope Protein gp120Receptors, HIVHIV ProteaseSexual PartnersSubstance Abuse, IntravenousPrevalenceHIV Long-Term SurvivorsCondomsUnsafe SexAIDS-Related Opportunistic InfectionsUgandaZimbabweHealth Knowledge, Attitudes, PracticeCoinfectionCounselingHIV EnteropathyRisk FactorsProstitutionCross-Sectional StudiesVoluntary ProgramsHIV Envelope Protein gp41Safe SexAfrica South of the SaharaMalawiAIDS Dementia ComplexEpidemicsZambiaHeterosexualityCircumcision, MaleHIV Fusion InhibitorsHIV Wasting SyndromeSyphilisHIV Integrase InhibitorsSocial StigmaStereotypingUnited StatesVirus ReplicationMass ScreeningSex WorkersHIV-2Patient Acceptance of Health CareHepatitis CPregnancyHIV SerosortingHomosexualityDrug Resistance, ViralIndiaTuberculosisInterviews as TopicRisk Reduction BehaviorKenyaIncidenceSubstance-Related DisordersDrug UsersTanzaniaHIV IntegrasePrisonersSocioeconomic FactorsQuestionnairesZidovudineTruth DisclosureRural PopulationBisexualityPopulation SurveillanceAnonymous TestingRwandaDeveloping CountriesPrisons